Evaluating the Role of Psilocybin Monitors in Psilocybin Therapy for Treatment Resistant Depression: A Pilot Randomized Clinical Trial
Psilocybin, the chemical component of "magic mushrooms", has been administered with psychological support in several randomized clinical trials (RCTs) showing large and sustained antidepressant effects. The purpose of this study is to determine the role of psilocybin monitors on the effects of psilocybin therapy in adults with treatment resistant depression.
- Status
- planned
- Phase
- Phase 2
- Institution
- Centre for Addiction and Mental Health
- Principal investigator
- Ishrat Husain, MD
- Start date
- 2026-04-01
- End date
- 2028-12-01
- Registry ID
- NCT07211438
Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.